Cargando…
Correction: Effective Therapeutic Approach for Head and Neck Cancer by an Engineered Minibody Targeting the EGFR Receptor
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312027/ https://www.ncbi.nlm.nih.gov/pubmed/25635398 http://dx.doi.org/10.1371/journal.pone.0117895 |
Ejemplares similares
-
Effective Therapeutic Approach for Head and Neck Cancer by an Engineered Minibody Targeting the EGFR Receptor
por: Kim, Young Pil, et al.
Publicado: (2014) -
Correction: Sioud et al. Evaluation of In Vitro Phototoxicity of a Minibody-IR700 Conjugate Using Monolayer and Multicellular Tumor Spheroid Models. Cancers 2021, 13, 3356
por: Sioud, Mouldy, et al.
Publicado: (2021) -
Correction: Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer
por: Xu, Naiqing, et al.
Publicado: (2018) -
The role of EGFR-targeting strategies in the treatment of head and neck cancer
por: Dequanter, Didier, et al.
Publicado: (2012) -
Correction: MMP-10/Stromelysin-2 Promotes Invasion of Head and Neck Cancer
por: Deraz, Elsayed Mohamed, et al.
Publicado: (2012)